Spotlight on the MedTech Industry

January 26, 2015 Erin Righetti

shutterstock_137426666The Medtech Trends and MoneyTree™ Investment Data report has recently been published and the medtech industry is profiting from more deals – however, the number of medtech companies receiving actual investment is down – so the fewer companies that are seeing investment are seeing more of it.The average deal value was up 28% in 2014 worth $2.66 billion total invested in 36 medtech firms. The average investment for each company saw $8.3 billion.  Mass Device has more.  Find out more about about 2014’s biotech investing in the Biotech trending high report from PWC.

Does the trend of bigger investments in fewer companies surprise you?  Why or why not?

Are you looking to meet with medtech investors? We’re hosting the Medtech Partnering Forum Japan this coming May 28-28 in Tokyo.  For more information on this year’s event and to register, visit the webpage.


Previous Article
Online engagement tools put drug developers in touch with patients
Online engagement tools put drug developers in touch with patients

Getting life saving and innovative drugs to market is a big job. It starts with ground breaking science, bu...

Next Article
Recursion Pharmaceuticals: Innovative alternative to drug discovery

Investment in biotech companies is increasing.  A recent article at Drug Discovery and Development shares t...